Latest period
$22.64B
YoY change
+44.3%
5Y CAGR
+136.3%
Peak year (2025)
$20.59B
Latest annual
$20.59B
Total Debt history chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: $20.59B
Total Debt growth chart for Novo Nordisk (NVO) from 1985 to 2025
Latest: +44.3%
Total Debt history table for Novo Nordisk (NVO) from 1985 to 2025
| 2025 | $20.59B | +44.3% | +$6.32B | ||
| 2024 | $14.27B | +256.9% | +$10.27B | ||
| 2023 | $4.00B | +7.7% | +$286.07M | ||
| 2022 | $3.71B | -8.9% | −$363.35M | ||
| 2021 | $4.08B | +1358.3% | +$3.80B | ||
| 2020 | $279.49M | +176.6% | +$178.43M | ||
| 2019 | $101.05M | +27.8% | +$21.97M | ||
| 2018 | $79.09M | -71.0% | −$193.92M | ||
| 2017 | $273.01M | +742.5% | +$240.61M | ||
| 2016 | $32.40M | -79.3% | −$123.88M | ||
| 2015 | $156.28M | +33.6% | +$39.27M | ||
| 2014 | $117.01M | +194.4% | +$77.27M | ||
| 2013 | $39.74M | -55.1% | −$48.71M | ||
| 2012 | $88.44M | -40.5% | −$60.30M | ||
| 2011 | $148.75M | -62.8% | −$250.61M | ||
| 2010 | $399.36M | +49.5% | +$132.18M | ||
| 2009 | $267.18M | -38.7% | −$168.62M | ||
| 2008 | $435.80M | +63.0% | +$168.45M | ||
| 2007 | $267.35M | -0.2% | −$669.23K | ||
| 2006 | $268.02M | -37.3% | −$159.41M | ||
| 2005 | $427.43M | +37.3% | +$116.06M | ||
| 2004 | $311.37M | +6.3% | +$18.36M | ||
| 2003 | $293.01M | — | — | ||
| 2002 | — | — | — | ||
| 2001 | — | — | — | ||
| 2000 | — | — | — | ||
| 1999 | — | — | — | ||
| 1998 | — | — | — | ||
| 1997 | — | — | — | ||
| 1996 | — | — | — | ||
| 1995 | — | — | — | ||
| 1994 | — | — | — | ||
| 1993 | — | — | — | ||
| 1992 | — | — | — | ||
| 1991 | — | — | — | ||
| 1990 | — | — | — | ||
| 1989 | — | — | — | ||
| 1988 | — | — | — | ||
| 1987 | — | — | — | ||
| 1986 | — | — | — | ||
| 1985 | — | — | — |
- 2025$20.59B+44.3%
- 2024$14.27B+256.9%
- 2023$4.00B+7.7%
- 2022$3.71B-8.9%
- 2021$4.08B+1358.3%
- 2020$279.49M+176.6%
- 2019$101.05M+27.8%
- 2018$79.09M-71.0%
- 2017$273.01M+742.5%
- 2016$32.40M-79.3%
- 2015$156.28M+33.6%
- 2014$117.01M+194.4%
- 2013$39.74M-55.1%
- 2012$88.44M-40.5%
- 2011$148.75M-62.8%
- 2010$399.36M+49.5%
- 2009$267.18M-38.7%
- 2008$435.80M+63.0%
- 2007$267.35M-0.2%
- 2006$268.02M-37.3%
- 2005$427.43M+37.3%
- 2004$311.37M+6.3%
- 2003$293.01M—
- 2002——
- 2001——
- 2000——
- 1999——
- 1998——
- 1997——
- 1996——
- 1995——
- 1994——
- 1993——
- 1992——
- 1991——
- 1990——
- 1989——
- 1988——
- 1987——
- 1986——
- 1985——
Total Debt values are taken from Novo Nordisk's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts converted to USD using IAS 21 average exchange rates (P&L / cash flow) or closing rates (balance sheet). Originally filed in DKK.
About Total Debt at Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported total debt is $22.64B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total debt for Novo Nordisk (NVO) came in at 130.96B DKK – grew 27.4% year-over-year.
Novo Nordisk total debt compound annual growth for the 2020–2025 (5 years) window is +138.4%, with mixed annual results across the window.
The highest annual total debt of 130.96B DKK was reported in 2025. The lowest in the available history was 215.00M DKK in 2013.
Novo Nordisk Total Debt by Year
Novo Nordisk Total Debt 2025: $20.59B
In 2025, Novo Nordisk reported total debt of 130.96B DKK ($20.59B), grew 27.4% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Total Debt 2024: $14.27B
Novo Nordisk total debt in 2024 was 102.79B DKK ($14.27B), surged 280.6% from 2023.
Novo Nordisk Total Debt 2023: $4.00B
2023's total debt for Novo Nordisk came in at 27.01B DKK ($4.00B), edged up 4.7% from 2022.
Novo Nordisk Total Debt 2022: $3.71B
Novo Nordisk posted total debt of 25.78B DKK ($3.71B) in 2022, edged down 3.2% below 2021.
Novo Nordisk Total Debt 2021: $4.08B
Novo Nordisk total debt in 2021 was 26.64B DKK ($4.08B).
See more financial history for Novo Nordisk (NVO).
Sector peers by Total Debt
Healthcare peers of Novo Nordisk (NVO), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $40.85B | |
| $29.70B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation